January 2, 2002 — SUNNYVALE, CA — Richard B. Brewer, president and CEO of Scios Inc. will present at the 20th Annual JPMorgan H&Q Healthcare Conference in San Francisco, California on Monday, January 7, at 2:00 p.m. (PST).
This presentation will be available to media, investors and the general public via a live webcast, accessible from Scios’ website, www.sciosinc.com. Go to the Investor section, then click on “Events and Presentations” for the link to the conference webcast. The webcast will be archived for 60 days.
During his approximately half-hour presentation, Mr. Brewer will review the status of the recent commercial launch of Scios’ flagship product, Natrecor (nesiritide) and outline the Company’s strategy and plans for 2002 to complete its transition to a top-tier commercial-stage biotechnology company.
Scios is a biopharmaceutical company developing novel treatments for cardiovascular and inflammatory disease.